Patent foramen ovale closure reduces the recurrence of cryptogenic ischemic stroke compared to antiplatelet therapy. Our goal was to determine procedure volumes and closure utilization as a proportion of candidates in four large European countries.
France
Patent foramen ovale closure reduces the recurrence of cryptogenic ischemic stroke compared to antiplatelet therapy. Our goal was to determine procedure volumes and closure utilization as a proportion of candidates in four large European countries.